Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Monoclonal antibody CT-P59 shows preclinical efficacy against South African SARS-CoV-2 variant

Monoclonal antibody CT-P59 shows preclinical efficacy against South African SARS-CoV-2 variant

Potent monoclonal antibody shows promise against emerging SARS-CoV-2 variants of concern

Potent monoclonal antibody shows promise against emerging SARS-CoV-2 variants of concern

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

The Native Antigen Company Launches SARS-CoV-2 Neutralisation Assay Development Kit

The Native Antigen Company Launches SARS-CoV-2 Neutralisation Assay Development Kit

New potential target for treating metastasized oral malignant melanoma in dogs

New potential target for treating metastasized oral malignant melanoma in dogs

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

Immune escape by SARS-CoV-2 mutations acquired in mink

Immune escape by SARS-CoV-2 mutations acquired in mink

Immune tolerance in hemophilia can be modulated by B cell activating factor

Immune tolerance in hemophilia can be modulated by B cell activating factor

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Self-assembling nanofibers can help limit damage caused by inflammatory diseases

Self-assembling nanofibers can help limit damage caused by inflammatory diseases

Early monoclonal antibody therapies beneficial for COVID-19, finds study

Early monoclonal antibody therapies beneficial for COVID-19, finds study

Risk of E.R. visit or hospitalization 82% lower in mAbs-treated SARS-CoV-2 patients: Study

Risk of E.R. visit or hospitalization 82% lower in mAbs-treated SARS-CoV-2 patients: Study

A host of mutations could compromise COVID-19 vaccines and antibody therapies

A host of mutations could compromise COVID-19 vaccines and antibody therapies

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Researchers identify several novel SARS-CoV-2 inhibitors

Researchers identify several novel SARS-CoV-2 inhibitors

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

Bispecific antibodies neutralize SARS-CoV-2 and its variants

Bispecific antibodies neutralize SARS-CoV-2 and its variants

Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants

Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants